FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:225-237 January 20, 2005 Number 3 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by McClellan, M. B. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

ABSTRACT

Background Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter–defibrillator (ICD) has been proposed to improve the prognosis in such patients.

Methods We randomly assigned 2521 patients with New York Heart Association (NYHA) class II or III CHF and a left ventricular ejection fraction (LVEF) of 35 percent or less to conventional therapy for CHF plus placebo (847 patients), conventional therapy plus amiodarone (845 patients), or conventional therapy plus a conservatively programmed, shock-only, single-lead ICD (829 patients). Placebo and amiodarone were administered in a double-blind fashion. The primary end point was death from any cause.

Results The median LVEF in patients was 25 percent; 70 percent were in NYHA class II, and 30 percent were in class III CHF. The cause of CHF was ischemic in 52 percent and nonischemic in 48 percent. The median follow-up was 45.5 months. There were 244 deaths (29 percent) in the placebo group, 240 (28 percent) in the amiodarone group, and 182 (22 percent) in the ICD group. As compared with placebo, amiodarone was associated with a similar risk of death (hazard ratio, 1.06; 97.5 percent confidence interval, 0.86 to 1.30; P=0.53) and ICD therapy was associated with a decreased risk of death of 23 percent (0.77; 97.5 percent confidence interval, 0.62 to 0.96; P=0.007) and an absolute decrease in mortality of 7.2 percentage points after five years in the overall population. Results did not vary according to either ischemic or nonischemic causes of CHF, but they did vary according to the NYHA class.

Conclusions In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.

Source Information

From the Seattle Institute for Cardiac Research (G.H.B., C.T., J.A., G.J.) and the University of Washington, Seattle (J.E.P., D.P.F.); Duke University, Durham, N.C. (K.L.L., D.B.M., S.E.M., N.C.-C., L.D.D.-R., E.S.F.); the Mayo Clinic, Rochester, Minn. (D.L.P.), the National Heart, Lung, and Blood Institute, Bethesda, Md. (R.B., M.D.), Florida Arrhythmia Consultants, Fort Lauderdale, Fla. (R.M.L.), and Ingham Medical Center, Lansing, Mich. (J.H.I.).

Address reprint requests to Dr. Bardy at the Seattle Institute for Cardiac Research, 7900 East Greenlake Dr. North, No. 300, Seattle, WA 98103, or at gbardy{at}sicr.org.

Full Text of this Article

Related Letters:

Implantable Cardioverter–Defibrillators
Mack M. J., Nash I., van Veldhuisen D. J., Voors A. A., Patwala A., Schlosshan D., Williams S. G., Bardy G. H., Lee K. L., Mark D. B., Kadish A. H., McClellan M. B., Tunis S. R.
Extract | Full Text | PDF  
N Engl J Med 2005; 352:2022-2025, May 12, 2005. Correspondence

This article has been cited by other articles:

• Mark, D. B., Anstrom, K. J., Sun, J. L., Clapp-Channing, N. E., Tsiatis, A. A., Davidson-Ray, L., Lee, K. L., Bardy, G. H., the Sudden Cardiac Death in Heart Failure Trial In, (2008). Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure. NEJM 359: 999-1008 [Abstract] [Full Text]  
• Poole, J. E., Johnson, G. W., Hellkamp, A. S., Anderson, J., Callans, D. J., Raitt, M. H., Reddy, R. K., Marchlinski, F. E., Yee, R., Guarnieri, T., Talajic, M., Wilber, D. J., Fishbein, D. P., Packer, D. L., Mark, D. B., Lee, K. L., Bardy, G. H. (2008). Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure. NEJM 359: 1009-1017 [Abstract] [Full Text]  
• Healey, J., Connolly, S. (2008). Life and Death after ICD Implantation. NEJM 359: 1058-1059 [Full Text]  
• Biffi, M., Ziacchi, M., Bertini, M., Sangiorgi, D., Corsini, D., Martignani, C., Diemberger, I., Boriani, G. (2008). Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 0: eun240v1-8 [Abstract] [Full Text]  
• Chapa, D. W., Lee, H.-J., Kao, C.-W., Friedmann, E., Thomas, S. A., Anderson, J., Bardy, G. H. (2008). Reducing Mortality With Device Therapy in Heart Failure Patients Without Ventricular Arrhythmias. Am J Crit Care 17: 443-452 [Abstract] [Full Text]  
• Masella, C., Zanaboni, P., Di Stasi, F., Gilardi, S., Ponzi, P., Valsecchi, S. (2008). Assessment of a remote monitoring system for implantable cardioverter defibrillators. J Telemed Telecare 14: 290-294 [Abstract] [Full Text]  
• Ding, L., Hua, W., Niu, H., Chen, K., Zhang, S. (2008). Primary prevention of sudden cardiac death using implantable cardioverter defibrillators. Europace 10: 1034-1041 [Abstract] [Full Text]  
• Theuns, D. A.M.J., Rivero-Ayerza, M., Goedhart, D. M., Miltenburg, M., Jordaens, L. J. (2008). Morphology discrimination in implantable cardioverter-defibrillators: consistency of template match percentage during atrial tachyarrhythmias at different heart rates. Europace 10: 1060-1066 [Abstract] [Full Text]  
• Schefer, T., Wolber, T., Binggeli, C., Holzmeister, J., Brunckhorst, C., Duru, F. (2008). Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function. Europace 10: 1052-1059 [Abstract] [Full Text]  
• Somers, J. R., Beck, P. L., Lees-Miller, J. P., Roach, D., Li, Y., Guo, J., Loken, S., Zhan, S., Semeniuk, L., Duff, H. J. (2008). iNOS in cardiac myocytes plays a critical role in death in a murine model of hypertrophy induced by calcineurin. Am. J. Physiol. Heart Circ. Physiol. 295: H1122-H1131 [Abstract] [Full Text]  
• Piccini, J. P., Hernandez, A. F., Dai, D., Thomas, K. L., Lewis, W. R., Yancy, C. W., Peterson, E. D., Fonarow, G. C., for the Get With the Guidelines Steering Committee, (2008). Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure. Circulation 118: 926-933 [Abstract] [Full Text]  
• Goldberger, J. J., Cain, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., Passman, R. S., Siscovick, D., Stevenson, W. G., Zipes, D. P. (2008). American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. J Am Coll Cardiol 0: j.jacc.2008.05.003v1-13938 [Full Text]  
• Tzeis, S., Andrikopoulos, G., Kolb, C., Vardas, P. E. (2008). Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace 0: eun205v1-10 [Abstract] [Full Text]  
• Anand, I. S. (2008). Anemia and Chronic Heart Failure: Implications and Treatment Options. J Am Coll Cardiol 52: 501-511 [Abstract] [Full Text]  
• Wilkoff, B. L., Williamson, B. D., Stern, R. S., Moore, S. L., Lu, F., Lee, S. W., Birgersdotter-Green, U. M., Wathen, M. S., Van Gelder, I. C., Heubner, B. M., Brown, M. L., Holloman, K. K., for the PREPARE Study Investigators, (2008). Strategic Programming of Detection and Therapy Parameters in Implantable Cardioverter-Defibrillators Reduces Shocks in Primary Prevention Patients: Results From the PREPARE (Primary Prevention Parameters Evaluation) Study. J Am Coll Cardiol 52: 541-550 [Abstract] [Full Text]  
• Blatt, J. A., Poole, J. E., Johnson, G. W., Callans, D. J., Raitt, M. H., Reddy, R. K., Marchlinski, F. E., Yee, R., Guarnieri, T., Talajic, M., Wilber, D. J., Anderson, J., Chung, K., Wong, W. S., Mark, D. B., Lee, K. L., Bardy, G. H., for the SCD-HeFT Investigators, (2008). No Benefit From Defibrillation Threshold Testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 52: 551-556 [Abstract] [Full Text]  
• Curtis, A. B. (2008). Defibrillation Threshold Testing in Implantable Cardioverter-Defibrillators: Might Less Be More Than Enough?. J Am Coll Cardiol 52: 557-558 [Full Text]  
• Cleland, J. G F, Tageldien, A., Maarouf, N., Hobson, N. (2008). Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely. Heart 94: 963-966 [Full Text]  
• Sacher, F., Tedrow, U. B., Field, M. E., Raymond, J.-M., Koplan, B. A., Epstein, L. M., Stevenson, W. G. (2008). Ventricular Tachycardia Ablation: Evolution of Patients and Procedures Over 8 Years. Circ Arrhythmia Electrophysiol 1: 153-161 [Abstract] [Full Text]  
• Witte, K. K., Pepper, C. B., Thomson, J. D., English, K. M. (2008). Letter by Witte et al Regarding Article, "Implantable Cardioverter-Defibrillators in Tetralogy of Fallot". Circulation 118: e99-e99 [Full Text]  
• Arvanitis, D. A., Sanoudou, D., Kolokathis, F., Vafiadaki, E., Papalouka, V., Kontrogianni-Konstantopoulos, A., Theodorakis, G. N., Paraskevaidis, I. A., Adamopoulos, S., Dorn, G. W. II, Kremastinos, D. Th., Kranias, E. G. (2008). The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. Eur Heart J 0: ehn328v1-12 [Abstract] [Full Text]  
• Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Stough, W. G., Gheorghiade, M., Heywood, J. T., McBride, M. L., Mehra, M. R., O'Connor, C. M., Reynolds, D., Walsh, M. N. (2008). Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF. Circ Heart Fail 1: 98-106 [Abstract] [Full Text]  
• Gasparini, M., Auricchio, A., Metra, M., Regoli, F., Fantoni, C., Lamp, B., Curnis, A., Vogt, J., Klersy, C., for the Multicentre Longitudinal Observational Stu, (2008). Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 29: 1644-1652 [Abstract] [Full Text]  
• Wu, K. C., Weiss, R. G., Thiemann, D. R., Kitagawa, K., Schmidt, A., Dalal, D., Lai, S., Bluemke, D. A., Gerstenblith, G., Marban, E., Tomaselli, G. F., Lima, J. A.C. (2008). Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.. J Am Coll Cardiol 51: 2414-2421 [Abstract] [Full Text]  
• Pavri, B. B., Hillis, M. B., Subacius, H., Brumberg, G. E., Schaechter, A., Levine, J. H., Kadish, A., for the Defibrillators in Nonischemic Cardiomyopat, (2008). Prognostic Value and Temporal Behavior of the Planar QRS-T Angle in Patients With Nonischemic Cardiomyopathy. Circulation 117: 3181-3186 [Abstract] [Full Text]  
• Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., Connolly, S. J., Dubuc, M., Ducharme, A., Guerra, P. G., Hohnloser, S. H., Lambert, J., Le Heuzey, J.-Y., O'Hara, G., Pedersen, O. D., Rouleau, J.-L., Singh, B. N., Stevenson, L. W., Stevenson, W. G., Thibault, B., Waldo, A. L., the Atrial Fibrillation and Congestive Heart Failu, (2008). Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure. NEJM 358: 2667-2677 [Abstract] [Full Text]  
• Kober, L., Torp-Pedersen, C., McMurray, J. J.V., Gotzsche, O., Levy, S., Crijns, H., Amlie, J., Carlsen, J., the Dronedarone Study Group, (2008). Increased Mortality after Dronedarone Therapy for Severe Heart Failure. NEJM 358: 2678-2687 [Abstract] [Full Text]  
• Cain, M. E., Curtis, A. B. (2008). Rhythm Control in Atrial Fibrillation -- One Setback after Another. NEJM 358: 2725-2727 [Full Text]  
• Zanon, F., Aggio, S., Baracca, E., Pastore, G., Corbucci, G., Boaretto, G., Braggion, G., Piergentili, C., Rigatelli, G., Roncon, L. (2008). Ventricular-arterial coupling in patients with heart failure treated with cardiac resynchronization therapy: may we predict the long-term clinical response?. Eur J Echocardiogr 0: jen184v1-6 [Abstract] [Full Text]  
• Nielsen, J. C., Kottkamp, H., Zabel, M., Aliot, E., Kreutzer, U., Bauer, A., Schuchert, A., Neuser, H., Schumacher, B., Schmidinger, H., Stix, G., Clementy, J., Danilovic, D., Hindricks, G. (2008). Automatic home monitoring of implantable cardioverter defibrillators. Europace 10: 729-735 [Abstract] [Full Text]  
• Scheinman, M. M., Keung, E. (2008). The Year in Review of Clinical Cardiac Electrophysiology. J Am Coll Cardiol 51: 2075-2081 [Full Text]  
• Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51: e1-e62 [Full Text]  
• Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Mark Estes, N.A. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51: 2085-2105 [Full Text]  
• Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117: 2820-2840 [Full Text]  
• Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N.A. M. III, Freedman, R. A., Gettes, L. S., Gillinov, A. M., Gregoratos, G., Hammill, S. C., Hayes, D. L., Hlatky, M. A., Newby, L. K., Page, R. L., Schoenfeld, M. H., Silka, M. J., Stevenson, L. W., Sweeney, M. O. (2008). ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117: e350-e408 [Full Text]  
• Eckstein, J., Koller, M. T., Zabel, M., Kalusche, D., Schaer, B. A., Osswald, S., Sticherling, C. (2008). Necessity for Surgical Revision of Defibrillator Leads Implanted Long-Term: Causes and Management. Circulation 117: 2727-2733 [Abstract] [Full Text]  
• MacDonald, M. R., Petrie, M. C., Hawkins, N. M., Petrie, J. R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., McMurray, J. J.V. (2008). Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 29: 1224-1240 [Abstract] [Full Text]  
• Carroll, D. L., Hamilton, G. A. (2008). Long-term Effects of Implanted Cardioverter-Defibrillators on Health Status, Quality of Life, and Psychological State. Am J Crit Care 17: 222-230 [Abstract] [Full Text]  
• Hoercher, K. J., Nowicki, E. R., Blackstone, E. H., Singh, G., Alster, J. M., Gonzalez-Stawinski, G. V., Starling, R. C., Young, J. B., Smedira, N. G. (2008). Prognosis of patients removed from a transplant waiting list for medical improvement: Implications for organ allocation and transplantation for status 2 patients.. J. Thorac. Cardiovasc. Surg. 135: 1159-1166 [Abstract] [Full Text]  
• Johansen, J. B., Pedersen, S. S., Spindler, H., Andersen, K., Nielsen, J. C., Mortensen, P. T. (2008). Symptomatic heart failure is the most important clinical correlate of impaired quality of life, anxiety, and depression in implantable cardioverter-defibrillator patients: a single-centre, cross-sectional study in 610 patients. Europace 10: 545-551 [Abstract] [Full Text]  
• Gibson, D. P., Kuntz, K. K., Levenson, J. L., Ellenbogen, K. A. (2008). Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator. Europace 10: 540-544 [Abstract] [Full Text]  
• Berul, C. I., Van Hare, G. F., Kertesz, N. J., Dubin, A. M., Cecchin, F., Collins, K. K., Cannon, B. C., Alexander, M. E., Triedman, J. K., Walsh, E. P., Friedman, R. A. (2008). Results of a Multicenter Retrospective Implantable Cardioverter-Defibrillator Registry of Pediatric and Congenital Heart Disease Patients. J Am Coll Cardiol 51: 1685-1691 [Abstract] [Full Text]  
• Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Toff, W. D., Tonkin, A. M., Smith, W., Dorian, P., Packer, D. L., White, R. D., Longstreth, W.T. Jr., Anderson, J., Johnson, G., Bischoff, E., Yallop, J. J., McNulty, S., Ray, L. D., Clapp-Channing, N. E., Rosenberg, Y., Schron, E. B., the HAT Investigators, (2008). Home Use of Automated External Defibrillators for Sudden Cardiac Arrest. NEJM 358: 1793-1804 [Abstract] [Full Text]  
• Mehta, R., Doshi, A. A., Hasan, A. K., Love, C. J., Pizzuto, M., Sai-Sudhakar, C., Chan, D. P. (2008). Device interactions in patients with advanced cardiomyopathy.. J Am Coll Cardiol 51: 1613-1614 [Full Text]  
• Moss, A. J. (2008). Life Versus Death. Circulation 117: 1912-1913 [Full Text]  
• Koller, M. T., Schaer, B., Wolbers, M., Sticherling, C., Bucher, H. C., Osswald, S. (2008). Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy: A Competing Risk Study. Circulation 117: 1918-1926 [Abstract] [Full Text]  
• Daubert, J. P., Zareba, W., Cannom, D. S., McNitt, S., Rosero, S. Z., Wang, P., Schuger, C., Steinberg, J. S., Higgins, S. L., Wilber, D. J., Klein, H., Andrews, M. L., Hall, W. J., Moss, A. J., for the MADIT II Investigators, (2008). Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II: Frequency, Mechanisms, Predictors, and Survival Impact. J Am Coll Cardiol 51: 1357-1365 [Abstract] [Full Text]  
• Raitt, M. H. (2008). Implantable Cardioverter-Defibrillator Shocks: A Double-Edged Sword?. J Am Coll Cardiol 51: 1366-1368 [Full Text]  
• Wellens, H. J. (2008). Forty Years of Invasive Clinical Electrophysiology: 1967-2007. Circ Arrhythmia Electrophysiol 1: 49-53 [Full Text]  
• Olshansky, B., Poole, J. E., Johnson, G., Anderson, J., Hellkamp, A. S., Packer, D., Mark, D. B., Lee, K. L., Bardy, G. H., for the SCD-HeFT Investigators, (2008). Syncope Predicts the Outcome of Cardiomyopathy Patients: Analysis of the SCD-HeFT Study. J Am Coll Cardiol 51: 1277-1282 [Abstract] [Full Text]  
• Santoro, A., Mancini, E., London, G., Mercadal, L., Fessy, H., Perrone, B., Cagnoli, L., Grandi, E., Severi, S., Cavalcanti, S. (2008). Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal. Nephrol Dial Transplant 23: 1415-1421 [Abstract] [Full Text]  
• Hare, J L, Jenkins, C, Nakatani, S, Ogawa, A, Yu, C-M, Marwick, T H (2008). Feasibility and clinical decision-making with 3D echocardiography in routine practice. Heart 94: 440-445 [Abstract] [Full Text]  
• Scott, P.A., Gorman, S., Andrews, N.P., Roberts, P.R., Kalra, P.R. (2008). Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006). Europace 10: 453-457 [Abstract] [Full Text]  
• Gardiwal, A., Yu, H., Oswald, H., Luesebrink, U., Ludwig, A., Pichlmaier, A. M., Drexler, H., Klein, G. (2008). Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator. Europace 10: 358-363 [Abstract] [Full Text]  
• Travin, M. I. (2008). A Potential Key Role for Radionuclide Imaging in the Prediction and Prevention of Sudden Arrhythmic Cardiac Death. JNM 49: 173-175 [Full Text]  
• Ptaszynski, P., Klingenheben, T., Gerritse, B., Kornet, L. (2008). Risk stratification after myocardial infarction: a new method of determining the neural component of the baroreflex is potentially more discriminative in distinguishing patients at high and low risk for arrhythmias. Europace 10: 227-234 [Abstract] [Full Text]  
• Stamato, N. J. (2008). Implantable Cardioverter-Defibrillators, Heart Failure, and Patient Characteristics. JAMA 299: 285-285 [Full Text]  
• Goldenberg, I., Vyas, A. K., Hall, W. J., Moss, A. J., Wang, H., He, H., Zareba, W., McNitt, S., Andrews, M. L., for the MADIT-II Investigators, (2008). Risk Stratification for Primary Implantation of a Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. J Am Coll Cardiol 51: 288-296 [Abstract] [Full Text]  
• Mittal, S. (2008). Selecting Patients for an Implantable Cardioverter-Defibrillator: Can the Genie Be Put Back Into the Bottle?. J Am Coll Cardiol 51: 297-299 [Full Text]  
• Khairy, P., Harris, L., Landzberg, M. J., Viswanathan, S., Barlow, A., Gatzoulis, M. A., Fernandes, S. M., Beauchesne, L., Therrien, J., Chetaille, P., Gordon, E., Vonder Muhll, I., Cecchin, F. (2008). Implantable Cardioverter-Defibrillators in Tetralogy of Fallot. Circulation 117: 363-370 [Abstract] [Full Text]  
• Spotnitz, H. M. (2008). Surgical Implantation of Pacemakers and Automatic Defibrillators. Card Surg Adult 3: 1395-1428 [Full Text]  
• Myles, R. C., Jackson, C. E., Tsorlalis, I., Petrie, M. C., McMurray, J. J. V., Cobbe, S. M. (2007). Is Microvolt T-Wave Alternans the Answer to Risk Stratification in Heart Failure?. Circulation 116: 2984-2991 [Full Text]  
• Coceani, M. (2007). Use of Amiodarone. JAMA 298: 2617-2618 [Full Text]  
• Exner, D. V., Kavanagh, K. M., Slawnych, M. P., Mitchell, L. B., Ramadan, D., Aggarwal, S. G., Noullett, C., Van Schaik, A., Mitchell, R. T., Shibata, M. A., Gulamhussein, S., McMeekin, J., Tymchak, W., Schnell, G., Gillis, A. M., Sheldon, R. S., Fick, G. H., Duff, H. J., for the REFINE Investigators, (2007). Noninvasive Risk Assessment Early After a Myocardial Infarction: The REFINE Study. J Am Coll Cardiol 50: 2275-2284 [Abstract] [Full Text]  
• Velazquez, E. J., Lee, K. L., O'Connor, C. M., Oh, J. K., Bonow, R. O., Pohost, G. M., Feldman, A. M., Mark, D. B., Panza, J. A., Sopko, G., Rouleau, J. L., Jones, R. H., STICH Investigators, (2007). The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.. J. Thorac. Cardiovasc. Surg. 134: 1540-1547.e4 [Abstract] [Full Text]  
• Sutton, R., Fisher, J. D., Linde, C., Benditt, D. G. (2007). History of electrical therapy for the heart. Eur Heart J Suppl 9: I3-I10 [Abstract] [Full Text]  
• Rossenbacker, T., Priori, S. G., Zipes, D. P. (2007). The fight against sudden cardiac death: consensus guidelines as a reference. Eur Heart J Suppl 9: I50-I58 [Abstract] [Full Text]  
• Jung, W., Schumacher, B. (2007). What is the role of risk stratification for sudden death in the defibrillator era?. Eur Heart J Suppl 9: I59-I65 [Abstract] [Full Text]  
• Boriani, G., Ricci, R., Toselli, T., Ferrari, R., Branzi, A., Santini, M. (2007). Implantable cardioverter defibrillators: from evidence of trials to clinical practice. Eur Heart J Suppl 9: I66-I73 [Abstract] [Full Text]  
• Sarkozy, A., Brugada, P., Mont, L., Brugada, J. (2007). Optimizing the clinical use of implantable defibrillators in patients with Brugada syndrome. Eur Heart J Suppl 9: I74-I80 [Abstract] [Full Text]  
• Padeletti, L., Pieragnoli, P., Jentzen, V., Schuchert, A. (2007). The comorbidity of atrial fibrillation and heart failure: a challenge for electrical therapies. Eur Heart J Suppl 9: I81-I86 [Abstract] [Full Text]  
• Kanjwal, Y., Imran, N., Kanjwal, K., Grubb, B. (2007). Piggy-back pacing: implantation of pacemaker and defibrillator on top of each other. Europace 9: 1191-1193 [Abstract] [Full Text]  
• De Ferrari, G. M., Rordorf, R., Frattini, F., Petracci, B., De Filippo, P., Landolina, M. (2007). Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator. Europace 9: 1151-1157 [Abstract] [Full Text]  
• Ritter, P., Cazeau, S., Gras, D., Daubert, J.-C. (2007). Cardiac resynchronization therapy implantation: a blend of skill and technology. Eur Heart J Suppl 9: I107-I112 [Abstract] [Full Text]  
• Passman, R., Subacius, H., Ruo, B., Schaechter, A., Howard, A., Sears, S. F., Kadish, A. (2007). Implantable Cardioverter Defibrillators and Quality of Life: Results From the Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation Study. Arch Intern Med 167: 2226-2232 [Abstract] [Full Text]  
• Salerno-Uriarte, J. A., De Ferrari, G. M., Klersy, C., Pedretti, R. F.E., Tritto, M., Sallusti, L., Libero, L., Pettinati, G., Molon, G., Curnis, A., Occhetta, E., Morandi, F., Ferrero, P., Accardi, F., for the ALPHA Study Group Investigators, (2007). Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy: Results of the ALPHA Study. J Am Coll Cardiol 50: 1896-1904 [Abstract] [Full Text]  
• Santini, M., Lavalle, C., Ricci, R. P. (2007). Primary and secondary prevention of sudden cardiac death: who should get an ICD?. Heart 93: 1478-1483 [Full Text]  
• Worck, R., Haarbo, J., Thomsen, P. E. B. (2007). Electrophysiological study and 'slow' ventricular tachycardia predict appropriate therapy: results from a single-centre implantable cardiac defibrillator follow-up. Europace 9: 1048-1053 [Abstract] [Full Text]  
• Kolettis, T. M., Agelaki, M. G., Baltogiannis, G. G., Vlahos, A. P., Mourouzis, I., Fotopoulos, A., Pantos, C. (2007). Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats. Europace 9: 1099-1104 [Abstract] [Full Text]  
• Rauwolf, T., Guenther, M., Hass, N., Schnabel, A., Bock, M., Braun, M.U., Strasser, R.H. (2007). Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions. Europace 9: 1041-1047 [Abstract] [Full Text]  
• Fleisher, L. A., Beckman, J. A., Brown, K. A., Calkins, H., Chaikof, E. L., Fleischmann, K. E., Freeman, W. K., Froehlich, J. B., Kasper, E. K., Kersten, J. R., Riegel, B., Robb, J. F., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Buller, C. E., Creager, M. A., Ettinger, S. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Tarkington, L. G., Yancy, C. W. (2007). ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50: e159-e242 [Full Text]  
• Fleisher, L. A., Beckman, J. A., Brown, K. A., Calkins, H., Chaikof, E. L., Fleischmann, K. E., Freeman, W. K., Froehlich, J. B., Kasper, E. K., Kersten, J. R., Riegel, B., Robb, J. F. (2007). ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 116: e418-e500 [Full Text]  
• Curtis, L. H., Al-Khatib, S. M., Shea, A. M., Hammill, B. G., Hernandez, A. F., Schulman, K. A. (2007). Sex Differences in the Use of Implantable Cardioverter-Defibrillators for Primary and Secondary Prevention of Sudden Cardiac Death. JAMA 298: 1517-1524 [Abstract] [Full Text]